How to Beat Cancer

|   Members RSVP   |  Apply to present  |  Participating companies  |  Guest Registration  | Home  |
 
 
DATE :  Tuesday, September 10th, 2013   ABSTRACT : 
Breathtaking advances in technology have provided an unprecedented view of how cancers operate; however despite these advances, cancer still kills millions of people each year. Conventional clinical trial designs, developed at a time when nobody understood the molecular complexity and diversity of cancer, have reached a point of diminishing returns. Dr. Tenenbaum will discuss an emerging rapid learning paradigm that tightly integrates research and clinical care in an effort to dramatically accelerate the rate of progress in treating cancer. More
VENUE :  KPMG - 3975 Freedom Circle, Santa Clara, CA 95054  
PROGRAM : 
5:00-6:00pm
Dinner, Networking & Exhibition
6:00-6:30pm Company Presentations
6:30-7:00pm Speaker Presentation, Q&A
7:00-7:30pm
Networking & Exhibition
 
SPEAKER : Marty Tenenbaum, Ph.D., Founder & Chairman, Cancer Commons

Marty Tenenbaum is a renowned computer scientist, Internet entrepreneur and cancer survivor. He founded Cancer Commons and CollabRx (NASD: CRLX) to help each cancer patient obtain the best possible outcome.  He was an Internet commerce pioneer, having founded or co-founded Enterprise Integration Technologies (1990, acquired by VeriFone), CommerceNet (1994), Veo Systems (1996, acquired by Commerce One), and Webify Solutions (2002, acquired by to IBM). He also served as an officer and Director of Medstory (acquired by Microsoft). 

Dr. Tenenbaum is a fellow and former board member of the American Association for Artificial Intelligence, and a former consulting professor of Computer Science at Stanford. He currently serves on the boards of Efficient Finance, Patients Like Me, and the Public Library of Science (PLoS). He holds B.S. and M.S. degrees in Electrical Engineering from MIT, and a Ph.D. from Stanford.

Cancer Commons is a non-profit open science initiative, where cancer patients are treated in accord with the latest knowledge, and that knowledge is continually updated based on each patient’s response.  Learn more at cancercommons.org.
 
VENUE
|   Members RSVP   |  Apply to present  |  Participating companies  |  Apply to become a member  |
 
Sponsors: